128 related articles for article (PubMed ID: 9639247)
1. Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment.
Löfberg C; Harro J; Matto V; Oreland L
Neuropeptides; 1998 Apr; 32(2):103-8. PubMed ID: 9639247
[TBL] [Abstract][Full Text] [Related]
2. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin peptides and receptors in the rat brain during stress.
Harro J; Löfberg C; Rehfeld JF; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):59-66. PubMed ID: 8832589
[TBL] [Abstract][Full Text] [Related]
4. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
Harro J; Häidkind R; Harro M; Modiri AR; Gillberg PG; Pähkla R; Matto V; Oreland L
Eur Neuropsychopharmacol; 1999 Dec; 10(1):5-16. PubMed ID: 10647090
[TBL] [Abstract][Full Text] [Related]
5. Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors.
Gustafsson H; de Araújo Lucas G; Schött E; Stiller CO; Alster P; Wiesenfeld-Hallin Z; Brodin E
Brain Res; 1998 Apr; 790(1-2):141-50. PubMed ID: 9593865
[TBL] [Abstract][Full Text] [Related]
6. Different molecular forms of cholecystokinin and CCKB receptor binding in the rat brain after chronic antidepressant treatment.
Harro J; Löfberg C; Pähkla R; Matto V; Rägo L; Oreland L; Allikmets L
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):57-63. PubMed ID: 9007843
[TBL] [Abstract][Full Text] [Related]
7. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.
Harro J; Oreland L; Vasar E; Bradwejn J
Eur Neuropsychopharmacol; 1995 Dec; 5(4):447-55. PubMed ID: 8998396
[TBL] [Abstract][Full Text] [Related]
8. The cholecystokinin system in the rat retina: receptor expression and in vivo activation of tyrosine phosphorylation pathways.
Bragado MJ; Perez-Marquez J; Garcia-Marin LJ
Neuropeptides; 2003 Dec; 37(6):374-80. PubMed ID: 14698681
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand.
Lodge DJ; Lawrence AJ
Regul Pept; 2001 Jun; 99(2-3):191-201. PubMed ID: 11384782
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin, acting through the A receptor subtype, stimulates the proliferative activity of adrenocortical cells and thymocytes in the rat.
Malendowicz LK; Tretjer M; de Caro R; Jedrzejczak N; Brelinska R; Markowska A; Nussdorfer GG; Nowak M
Histol Histopathol; 1999 Apr; 14(2):439-43. PubMed ID: 10212804
[TBL] [Abstract][Full Text] [Related]
11. Housing influences exploration and social interaction of control and DSP-4-treated rats.
Cornwell-Jones CA; Palfai T; Krasenbaum D; Byer E; Clark R; Kinnard K
Physiol Behav; 1992 Aug; 52(2):271-6. PubMed ID: 1381838
[TBL] [Abstract][Full Text] [Related]
12. Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.
Harro J; Lang A; Vasar E
Eur J Pharmacol; 1990 May; 180(1):77-83. PubMed ID: 2365005
[TBL] [Abstract][Full Text] [Related]
13. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning.
Heal DJ; Butler SA; Prow MR; Buckett WR
Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites.
Ladurelle N; Sebret A; Garbay C; Roques BP; Daugé V
Br J Pharmacol; 1998 Jul; 124(6):1091-8. PubMed ID: 9720778
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
17. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
20. Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats.
Lu L; Huang M; Ma L; Li J
Behav Brain Res; 2001 Apr; 120(1):105-10. PubMed ID: 11173090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
